DUOS TECHNOLOGIES GROUP INC (DUOT) Fundamental Analysis & Valuation

NASDAQ:DUOT • US2660424076

Current stock price

6.295 USD
-0.7 (-9.94%)
At close:
6.365 USD
+0.07 (+1.11%)
Pre-Market:

This DUOT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DUOT Profitability Analysis

1.1 Basic Checks

  • In the past year DUOT has reported negative net income.
  • In the past year DUOT has reported a negative cash flow from operations.
  • DUOT had negative earnings in each of the past 5 years.
  • In the past 5 years DUOT always reported negative operating cash flow.
DUOT Yearly Net Income VS EBIT VS OCF VS FCFDUOT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • DUOT has a worse Return On Assets (-14.39%) than 69.45% of its industry peers.
  • The Return On Equity of DUOT (-20.29%) is worse than 61.09% of its industry peers.
Industry RankSector Rank
ROA -14.39%
ROE -20.29%
ROIC N/A
ROA(3y)-56.91%
ROA(5y)-67.89%
ROE(3y)-284.96%
ROE(5y)-396.89%
ROIC(3y)N/A
ROIC(5y)N/A
DUOT Yearly ROA, ROE, ROICDUOT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K 1.5K

1.3 Margins

  • The Gross Margin of DUOT (26.38%) is worse than 80.00% of its industry peers.
  • DUOT's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for DUOT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.38%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-32.94%
DUOT Yearly Profit, Operating, Gross MarginsDUOT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. DUOT Health Analysis

2.1 Basic Checks

  • DUOT does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, DUOT has more shares outstanding
  • Compared to 5 years ago, DUOT has more shares outstanding
  • Compared to 1 year ago, DUOT has a worse debt to assets ratio.
DUOT Yearly Shares OutstandingDUOT Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
DUOT Yearly Total Debt VS Total AssetsDUOT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

  • DUOT has an Altman-Z score of 4.17. This indicates that DUOT is financially healthy and has little risk of bankruptcy at the moment.
  • DUOT has a Altman-Z score of 4.17. This is in the better half of the industry: DUOT outperforms 74.18% of its industry peers.
  • DUOT has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • With a decent Debt to Equity ratio value of 0.00, DUOT is doing good in the industry, outperforming 67.64% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 4.17
ROIC/WACCN/A
WACC11.04%
DUOT Yearly LT Debt VS Equity VS FCFDUOT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M

2.3 Liquidity

  • DUOT has a Current Ratio of 3.85. This indicates that DUOT is financially healthy and has no problem in meeting its short term obligations.
  • DUOT has a Current ratio of 3.85. This is amongst the best in the industry. DUOT outperforms 81.45% of its industry peers.
  • A Quick Ratio of 3.80 indicates that DUOT has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 3.80, DUOT belongs to the best of the industry, outperforming 80.73% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.85
Quick Ratio 3.8
DUOT Yearly Current Assets VS Current LiabilitesDUOT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. DUOT Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 33.57% over the past year.
  • The Revenue has grown by 159.00% in the past year. This is a very strong growth!
  • Measured over the past years, DUOT shows a very negative growth in Revenue. The Revenue has been decreasing by -11.80% on average per year.
EPS 1Y (TTM)33.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)159%
Revenue growth 3Y-4.12%
Revenue growth 5Y-11.8%
Sales Q2Q%112.33%

3.2 Future

  • The Earnings Per Share is expected to grow by 44.48% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, DUOT will show a very strong growth in Revenue. The Revenue will grow by 116.16% on average per year.
EPS Next Y69.4%
EPS Next 2Y44.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year222.4%
Revenue Next 2Y116.16%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
DUOT Yearly Revenue VS EstimatesDUOT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 10M 20M 30M 40M
DUOT Yearly EPS VS EstimatesDUOT Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -2 -4 -6 -8

More info and screens

Find the best growth stocksShow best growing peers

2

4. DUOT Valuation Analysis

4.1 Price/Earnings Ratio

  • DUOT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 51.43, DUOT can be considered very expensive at the moment.
  • The rest of the industry has a similar Price/Forward Earnings ratio as DUOT.
  • The average S&P500 Price/Forward Earnings ratio is at 22.10. DUOT is valued rather expensively when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 51.43
DUOT Price Earnings VS Forward Price EarningsDUOT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DUOT Per share dataDUOT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 1.5

4.3 Compensation for Growth

  • DUOT's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DUOT's earnings are expected to grow with 44.48% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.48%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DUOT Dividend Analysis

5.1 Amount

  • No dividends for DUOT!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DUOT Fundamentals: All Metrics, Ratios and Statistics

DUOS TECHNOLOGIES GROUP INC

NASDAQ:DUOT (3/30/2026, 8:00:02 PM)

Premarket: 6.365 +0.07 (+1.11%)

6.295

-0.7 (-9.94%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-13
Earnings (Next)03-31
Inst Owners36.72%
Inst Owner Change-4.59%
Ins Owners15.61%
Ins Owner Change0.56%
Market Cap185.95M
Revenue(TTM)19.03M
Net Income(TTM)-10.04M
Analysts82.86
Price Target14.28 (126.85%)
Short Float %6.1%
Short Ratio3.23
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.09%
Min EPS beat(2)-36.8%
Max EPS beat(2)50.98%
EPS beat(4)2
Avg EPS beat(4)-5.03%
Min EPS beat(4)-36.8%
Max EPS beat(4)50.98%
EPS beat(8)4
Avg EPS beat(8)-11.13%
EPS beat(12)6
Avg EPS beat(12)-15.21%
EPS beat(16)9
Avg EPS beat(16)-10.86%
Revenue beat(2)1
Avg Revenue beat(2)2.98%
Min Revenue beat(2)-7.64%
Max Revenue beat(2)13.61%
Revenue beat(4)2
Avg Revenue beat(4)-7.26%
Min Revenue beat(4)-47.91%
Max Revenue beat(4)13.61%
Revenue beat(8)4
Avg Revenue beat(8)-9.04%
Revenue beat(12)5
Avg Revenue beat(12)-12.91%
Revenue beat(16)7
Avg Revenue beat(16)-7.32%
PT rev (1m)0%
PT rev (3m)21.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-200%
EPS NY rev (1m)0%
EPS NY rev (3m)8.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.43%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 51.43
P/S 9.77
P/FCF N/A
P/OCF N/A
P/B 3.76
P/tB 4.53
EV/EBITDA N/A
EPS(TTM)-0.95
EYN/A
EPS(NY)0.12
Fwd EY1.94%
FCF(TTM)-0.56
FCFYN/A
OCF(TTM)-0.28
OCFYN/A
SpS0.64
BVpS1.68
TBVpS1.39
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -14.39%
ROE -20.29%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.38%
FCFM N/A
ROA(3y)-56.91%
ROA(5y)-67.89%
ROE(3y)-284.96%
ROE(5y)-396.89%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y-32.94%
F-Score5
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 314.17%
Cap/Sales 42.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.85
Quick Ratio 3.8
Altman-Z 4.17
F-Score5
WACC11.04%
ROIC/WACCN/A
Cap/Depr(3y)154.97%
Cap/Depr(5y)158.63%
Cap/Sales(3y)14.73%
Cap/Sales(5y)10.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)33.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y69.4%
EPS Next 2Y44.48%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)159%
Revenue growth 3Y-4.12%
Revenue growth 5Y-11.8%
Sales Q2Q%112.33%
Revenue Next Year222.4%
Revenue Next 2Y116.16%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y14.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year103.24%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y13.84%
OCF growth 3YN/A
OCF growth 5YN/A

DUOS TECHNOLOGIES GROUP INC / DUOT Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DUOS TECHNOLOGIES GROUP INC?

ChartMill assigns a fundamental rating of 3 / 10 to DUOT.


What is the valuation status of DUOS TECHNOLOGIES GROUP INC (DUOT) stock?

ChartMill assigns a valuation rating of 2 / 10 to DUOS TECHNOLOGIES GROUP INC (DUOT). This can be considered as Overvalued.


Can you provide the profitability details for DUOS TECHNOLOGIES GROUP INC?

DUOS TECHNOLOGIES GROUP INC (DUOT) has a profitability rating of 0 / 10.


What is the expected EPS growth for DUOS TECHNOLOGIES GROUP INC (DUOT) stock?

The Earnings per Share (EPS) of DUOS TECHNOLOGIES GROUP INC (DUOT) is expected to grow by 69.4% in the next year.